Core Points - The company announced the issuance of the third phase of its 2025 renewable corporate bonds by its wholly-owned subsidiary, China Global Leasing Co., Ltd [1] - The total principal amount of the bonds issued is RMB 300 million, with a fixed interest rate of 2.05% [1] - The bonds were successfully issued in China on October 28, 2025, with a basic term of 1 year [1] - The issuer has the right to exercise the renewal option at the end of the basic term and at the end of each renewal period [1] - The issuance price of the bonds is RMB 100 per bond, equivalent to 100% of the face value [1]

Core Viewpoint - The company announced the issuance of its third phase of renewable corporate bonds for 2025, totaling RMB 300 million, with a fixed interest rate of 2.05% [1] Group 1: Bond Issuance Details - The bonds were issued by the company's wholly-owned subsidiary, China Global Leasing Co., Ltd., within China [1] - The total principal amount of the bonds issued is RMB 300 million, with a base term of 1 year starting from October 28, 2025 [1] - The issuance price is set at RMB 100 per bond, equivalent to 100% of the bond's face value [1] Group 2: Terms and Conditions - The issuer has the right to exercise the renewal option at the end of the base term and at the end of each renewal cycle [1] - The fixed interest rate for the bonds is 2.05% [1]

Core Viewpoint - Global Medical (02666.HK) has issued the third phase of its 2025 renewable corporate bonds in China, totaling RMB 300 million with a fixed interest rate of 2.05% [1] Group 1: Bond Issuance Details - The total principal amount of the bonds issued is RMB 300 million [1] - The bonds have a base term of 1 year starting from October 28, 2025 [1] - The issuance price is set at RMB 100 per bond, equivalent to the face value of the bonds [1] Group 2: Renewal Option - The issuer has the right to exercise a renewal option at the end of the base term and at the end of each renewal cycle [1]